These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3246568

  • 1. Application site dependent ocular absorption of timolol.
    Urtti A, Sendo T, Pipkin JD, Rork G, Repta AJ.
    J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
    [Abstract] [Full Text] [Related]

  • 2. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K, Urtti A.
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic differences between ocular inserts and eyedrops.
    Friedrich SW, Saville BA, Cheng YL, Rootman DS.
    J Ocul Pharmacol Ther; 1996 Sep; 12(1):5-18. PubMed ID: 8925396
    [Abstract] [Full Text] [Related]

  • 4. Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit.
    Ohdo S, Zhu J, Lee VH.
    Life Sci; 1992 Sep; 51(26):2025-31. PubMed ID: 1474859
    [Abstract] [Full Text] [Related]

  • 5. In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits.
    Sasaki H, Ichikawa M, Kawakami S, Yamamura K, Mukai T, Nishida K, Nakamura J.
    J Pharm Pharmacol; 1997 Feb; 49(2):140-4. PubMed ID: 9055184
    [Abstract] [Full Text] [Related]

  • 6. Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.
    Fayyaz A, Vellonen KS, Ranta VP, Toropainen E, Reinisalo M, Valtari A, Puranen J, Ricci GD, Heikkinen EM, Gardner I, Ruponen M, Urtti A, Jamei M, Del Amo EM.
    Eur J Pharm Biopharm; 2021 Sep; 166():155-162. PubMed ID: 34139290
    [Abstract] [Full Text] [Related]

  • 7. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
    Acheampong AA, Breau A, Shackleton M, Luo W, Lam S, Tang-Liu DD.
    J Ocul Pharmacol Ther; 1995 Sep; 11(4):489-502. PubMed ID: 8574812
    [Abstract] [Full Text] [Related]

  • 8. Comparative distribution of pilocarpine in ocular tissues of the rabbit during administration by eyedrop or by membrane-controlled delivery systems.
    Sendelbeck L, Moore D, Urquhart J.
    Am J Ophthalmol; 1975 Aug; 80(2):274-83. PubMed ID: 1155567
    [Abstract] [Full Text] [Related]

  • 9. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
    Ahmed I, Patton TF.
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH, Luo AM, Li SY, Podder SK, Chang JS, Ohdo S, Grass GM.
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [Abstract] [Full Text] [Related]

  • 11. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
    Bito LZ, Baroody RA.
    Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
    [Abstract] [Full Text] [Related]

  • 12. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.
    Acheampong AA, Shackleton M, Tang-Liu DD, Ding S, Stern ME, Decker R.
    Curr Eye Res; 1999 Feb; 18(2):91-103. PubMed ID: 10223652
    [Abstract] [Full Text] [Related]

  • 13. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S, Grass GM, Lee VH.
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [Abstract] [Full Text] [Related]

  • 14. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
    Tan AY, LeVatte TL, Archibald ML, Tremblay F, Kelly ME, Chauhan BC.
    J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
    [Abstract] [Full Text] [Related]

  • 15. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
    Lee VH, Yamahara H, Gurny R, Sintzel MB, Martenet M, Gex-Fabry M, Balant L, Ohdo S, Podder SK.
    J Ocul Pharmacol Ther; 1996 Apr; 12(2):103-13. PubMed ID: 8773926
    [Abstract] [Full Text] [Related]

  • 16. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K, Urtti A.
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [Abstract] [Full Text] [Related]

  • 17. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.
    Chang SC, Chien DS, Bundgaard H, Lee VH.
    Exp Eye Res; 1988 Jan; 46(1):59-69. PubMed ID: 3342834
    [Abstract] [Full Text] [Related]

  • 18. Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: absorption, disposition, and non-compartmental analysis.
    Pamulapati CR, Schoenwald RD.
    J Pharm Sci; 2011 Dec; 100(12):5315-23. PubMed ID: 21850670
    [Abstract] [Full Text] [Related]

  • 19. Ocular tissue absorption of gentamicin.
    Golden B, Coppel SP.
    Arch Ophthalmol; 1970 Dec; 84(6):792-6. PubMed ID: 5487446
    [No Abstract] [Full Text] [Related]

  • 20. Microemulsions as topical delivery vehicles: ocular administration of timolol.
    Gasco MR, Gallarate M, Trotta M, Bauchiero L, Gremmo E, Chiappero O.
    J Pharm Biomed Anal; 1989 Dec; 7(4):433-9. PubMed ID: 2490750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.